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 When an injured patient presents to a non-trauma hospital, and a provider 
determines that the needs of the patient exceed the capabilities of the hospital, she 
faces a critical decision: where to send the patient? Hospital referral patterns may be 
predetermined by inter-facility transfer agreements, but they may also be informed by 
evidence regarding hospital outcomes. For example, a limited amount of evidence 
suggests that patients with traumatic brain injuries (TBIs) have improved survival when 
treated at ACS Level I trauma centers compared with ACS Level II trauma centers.1, 2 
While those studies favor the transfer of TBI patients to ACS Level I trauma centers, the 
amount and quality of evidence supporting that decision is quite limited. One of the 
studies cited above uses data that predates current ACS trauma center verification 
criteria, while the other uses data that is limited to a single state. 
 Given this paucity of evidence and the lack of a distinction between clinically 
relevant resources at ACS Levels I and II trauma centers,3 the authors of this study 
postulated that these two types of trauma centers actually achieve equivalent clinical 
outcomes for TBI patients. To test their hypothesis, the authors used nationally 
representative data to develop a risk-adjusted model for in-patient mortality of TBI 
patients who underwent inter-facility transfer. Then, they tested for a mortality difference 
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 The finding that no statistically significant difference existed between types of 
trauma centers is provocative and has potentially consequential policy implications for 
trauma systems. First, the findings of this study challenge previous studies that found 
that ACS Level I trauma centers impart a survival benefit over Level II trauma centers. 
The negative findings of this study may, in fact, reflect that trauma systems are 
generally functioning as intended: mortality has been optimized by the selective referral 
of more severely injured patients to ACS Level I trauma centers, while patients with less 
complex injuries are selectively transferred to ACS Level II trauma centers. Mortality, 
however, is a blunt measure of healthcare quality. It is worth noting that Level II trauma 
centers appeared in this study to have a greater rate of unadjusted complications 
compared with Level I trauma centers, and significant differences in other study 
outcomes appeared to exist as well (Table 2). Unfortunately, the study does not report 
adjusted differences in those outcomes. 
 Given the findings of this study, it is reasonable to infer that ACS Level II trauma 
centers provide a safe alternative to ACS Level I trauma centers for the management of 
patients with isolated TBIs. As the authors suggest, EMS providers managing those 
patients should not necessarily bypass ACS Level II facilities while performing an inter-
facility transfer, given that their local knowledge supports the literature. Increased 
utilization of ACS Level II centers for the care of patients with isolated TBIs has the 
potential to increase access to care and may allow patients to remain closer to their 
families and/or support communities. Furthermore, these policy implications are 
particularly timely, given that many hospitals are experiencing unprecedented capacity 
strain secondary to the COVID-19 pandemic. As leaders of Level I trauma programs 
seek preserve capacity for the more severely injured patients and avoid diversion status, 
they may explore coordinating with ACS Level II trauma centers to direct isolated TBI 
patients to those facilities. Unfortunately, virtually all hospitals are experiencing some 
form of capacity strain currently, not just ACS Level I trauma centers, and it is unclear 
whether ACS Level II trauma centers can safely accommodate increased trauma 
volume. 
 Of course, the findings of this study should be interpreted in the context of its 
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adjusted manner, so one cannot draw a fuller understanding of how trauma quality 
compares between the different types of trauma centers beyond in-hospital mortality. 
Also, the rationale for certain statistical methods is not fully explained (e.g., transforming 
continuous variables like systolic blood pressure into dichotomous variables) and would 
seem to compromise the statistical power of the analyses. The ACS risk-adjustment 
methods are well described, and deviation from those methods should be justified.4 
Further, it is curious that GCS was not included in the multivariable model, given its 
prevalence in existing neurotrauma literature and high prognostic value. Since the study 
cohorts were likely influenced by selection biases of the referring hospitals, a propensity 
score matched approach to the analyses may have yielded results that better account 
for those unmeasured biases. Finally, the study is constrained by the data itself, since 
the authors were unable to account for variations in pre-trauma center care and trauma 
center proximity that may have resulted in delays in therapy and influenced patient 
outcomes.5 Despite these limitations, the risk-adjusted mortality model produced a C-
statistic of 0.83, reflecting a sound predictive model, so the results of the analyses and 
their policy implications warrant consideration. 
 The authors seek to attribute their findings to changes in the guidelines for ACS 
trauma center verification, stating that the previous literature that demonstrated 
differences in outcomes between ACS Level I and Level II trauma centers used data 
that predated the publication of the most recent ACS trauma center verification 
requirements. However, we submit that other study designs (e.g., difference-in-
difference) would be more appropriate to examine the association between changes in 
health policy and clinical outcomes.6 For that reason, as well as the fact that more 
recent data suggest that differences persist between outcomes at ACS Level I and 
Level II trauma centers,1 attribution of this study’s findings to changes in policy are 
unwarranted. 
 In short, the effective coordination of care between non-trauma hospitals and 
trauma centers is a cornerstone of the trauma system of care, and appropriate trauma 
center selection should be informed by one’s local knowledge and the best available 
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regarding the safety of inter-facility transfer to ACS Level I and Level II trauma centers 
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